{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:17:43Z","timestamp":1791944263084,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["NWA.1160.18.038"],"award-info":[{"award-number":["NWA.1160.18.038"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Health Care and Philos"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of gene therapy has always come with the expectation that it will offer a cure for various disorders, of which hemophilia is a paradigm example. However, although the term is used regularly, it is unclear what exactly is meant with \u201ccure\u201d. Therefore, the aim of this paper is to analyse how the concept of cure is used in practice and evaluate which of the interpretations is most suitable in discussions surrounding gene therapy. We analysed how cure is used in four different medical fields where the concept raises discussion. We show that cure can be used in three different ways: cure as normalization of the body, cure as obtaining a normal life, or cure as a change in identity. We argue that since cure is a practical term, its interpretation should be context-specific and the various uses can exist simultaneously, as long as their use is suitable to the function the notion of cure plays in each of the settings. We end by highlighting three different settings in the domain of hemophilia gene therapy in which the term cure is used and explore the function(s) it serves in each setting. We conclude that in the clinical application of gene therapy, it could be better to abandon the term cure, whereas more modest and specified definitions of cure are required in the context of health resource allocation decisions and decisions on research funding.<\/jats:p>","DOI":"10.1007\/s11019-024-10223-w","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:17:50Z","timestamp":1724422670000},"page":"489-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["What is a cure through gene therapy? An analysis and evaluation of the use of \u201ccure\u201d"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-2712","authenticated-orcid":false,"given":"Lieke","family":"Baas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelien L.","family":"Bredenoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"16","key":"10223_CR1","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/jama.2012.13258","volume":"308","author":"AB Astrow","year":"2012","unstructured":"Astrow, A. B. 2012. Cancer survivorship and beyond. Journal of the American Medical Association 308(16): 1639\u20131640.","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10223_CR2","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/J.RPTH.2023.102237","volume":"7","author":"L Baas","year":"2023","unstructured":"Baas, L., K. Meijer, M. Driessens, A. L. Bredenoord, R. van der Graaf, and for the SYMPHONY consortium. 2023. Ethical aspects of hemophilia gene therapy: A qualitative interview study with stakeholders. Research and Practice in Thrombosis and Haemostasis 7(7): 102237. https:\/\/doi.org\/10.1016\/J.RPTH.2023.102237","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"3","key":"10223_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1176\/APPI.PS.201100248","volume":"63","author":"ME Barber","year":"2012","unstructured":"Barber, M. E. 2012. Recovery as the New Medical Model for Psychiatry. Psychiatric Services 63(3): 277\u2013279. https:\/\/doi.org\/10.1176\/APPI.PS.201100248","journal-title":"Psychiatric Services"},{"issue":"1","key":"10223_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/09687599.2011.529662","volume":"26","author":"K Beauchamp-Pryor","year":"2011","unstructured":"Beauchamp-Pryor, K. 2011. Impairment, cure and identity: Where do i fit in? Disability and Society 26(1): 5\u201317. https:\/\/doi.org\/10.1080\/09687599.2011.529662","journal-title":"Disability and Society"},{"key":"10223_CR5","doi-asserted-by":"crossref","unstructured":"Boorse, C. 1997. A rebuttal on Health. In What is disease?, 1\u2013134. Humana.","DOI":"10.1007\/978-1-59259-451-1_1"},{"key":"10223_CR6","unstructured":"ClinicalTrials. 2019. gov. https:\/\/clinicaltrials.gov\/study\/NCT03961243?cond=hemophilia&term=gene%20therapy&rank=6"},{"key":"10223_CR7","unstructured":"Clinicaltrials. 2023. gov. https:\/\/clinicaltrials.gov\/study\/NCT03001830?cond=hemophilia&term=gene%20therapy&page=2&rank=12"},{"key":"10223_CR8","doi-asserted-by":"publisher","unstructured":"Corn, B. W., D. Feldman, L. Schapira, D. P. Steensma, C. L. Loprinzi, and J. Bian. 2020. Oncologists\u2019 reluctance to use the terms hope and cure: A bibliometric analysis of Articles from two high-impact oncology journals. JNCI Cancer Spectrum 4(6). https:\/\/doi.org\/10.1093\/JNCICS\/PKAA065","DOI":"10.1093\/JNCICS\/PKAA065"},{"issue":"4","key":"10223_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/JMP\/JHX011","volume":"42","author":"L De Vreese","year":"2017","unstructured":"De Vreese, L. 2017. How to proceed in the Disease Concept Debate? A pragmatic Approach. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine 42(4): 424\u2013446. https:\/\/doi.org\/10.1093\/JMP\/JHX011","journal-title":"The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine"},{"issue":"2","key":"10223_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2516.2003.00725.x","volume":"9","author":"D DiMichele","year":"2003","unstructured":"DiMichele, D., F. G. Miller, and J. J. Fins. 2003. Gene therapy ethics and haemophilia: An inevitable therapeutic future? Haemophilia 9(2): 145\u2013152. https:\/\/doi.org\/10.1046\/j.1365-2516.2003.00725.x","journal-title":"Haemophilia"},{"key":"10223_CR11","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/S1470-2045(16)30452-1","volume":"17","author":"A Dumas","year":"2016","unstructured":"Dumas, A., F. De Vathaire, and G. Vassal. 2016. Access to loan-related insurance for French cancer survivors. The Lancet Oncology 17: 1354\u20131356.","journal-title":"The Lancet Oncology"},{"issue":"3","key":"10223_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1370\/AFM.313","volume":"3","author":"TR Egnew","year":"2005","unstructured":"Egnew, T. R. 2005. The meaning of Healing: Transcending suffering. Annals of Family Medicine 3(3): 255. https:\/\/doi.org\/10.1370\/AFM.313","journal-title":"Annals of Family Medicine"},{"issue":"5","key":"10223_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14378","volume":"27","author":"S Fletcher","year":"2021","unstructured":"Fletcher, S., K. Jenner, M. Holland, S. Chaplin, and K. Khair. 2021. An exploration of why men with severe haemophilia might not want gene therapy: The exigency study. Haemophilia 27(5): 1\u20139. https:\/\/doi.org\/10.1111\/hae.14378","journal-title":"Haemophilia"},{"issue":"5","key":"10223_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1055\/S-0034-1381232\/ID\/JR02087-18\/BIB","volume":"40","author":"M Franchini","year":"2014","unstructured":"Franchini, M., and P. M. Mannucci. 2014. The history of hemophilia. Seminars in Thrombosis and Hemostasis 40(5): 571\u2013576. https:\/\/doi.org\/10.1055\/S-0034-1381232\/ID\/JR02087-18\/BIB","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10223_CR15","unstructured":"Gallagher, J. 2022. Transformational therapy cures haemophilia B. BBC News."},{"issue":"5509","key":"10223_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1126\/SCIENCE.291.5509.1692\/ASSET\/C91F1A99-462E-4F73-9EEB-75E30E463989\/ASSETS\/GRAPHIC\/1692-5.GIF","volume":"291","author":"T Gura","year":"2001","unstructured":"Gura, T. 2001. After a setback, gene therapy progresses \u2026 gingerly. Science 291(5509): 1692\u20131697. https:\/\/doi.org\/10.1126\/SCIENCE.291.5509.1692\/ASSET\/C91F1A99-462E-4F73-9EEB-75E30E463989\/ASSETS\/GRAPHIC\/1692-5.GIF","journal-title":"Science"},{"key":"10223_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/J.DRUGPO.2017.03.015","volume":"47","author":"M Harris","year":"2017","unstructured":"Harris, M. 2017. Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment \u2018benefit\u2019. International Journal of Drug Policy 47: 161\u2013168. https:\/\/doi.org\/10.1016\/J.DRUGPO.2017.03.015","journal-title":"International Journal of Drug Policy"},{"key":"10223_CR18","doi-asserted-by":"publisher","unstructured":"Hassan, S., R. C. Monahan, E. P. Mauser-Bunschoten, L. F. D. van Vulpen, J. Eikenboom, E. A. M. Beckers, L. Hooimeijer, P. F. Ypma, L. Nieuwenhuizen, M. Coppens, S. E. M. Schols, F. W. G. Leebeek, C. Smit, M. H. Driessens, S. le Cessie, E. C. van Balen, F. R. Rosendaal, J. G. van Bom der, and S. C. Gouw. 2021. Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001\u20132018. Journal of Thrombosis and Haemostasis, 19(3), 645\u2013653. https:\/\/doi.org\/10.1111\/JTH.15182","DOI":"10.1111\/JTH.15182"},{"key":"10223_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jmp\/jhy011","volume":"43","author":"B Haverkamp","year":"2018","unstructured":"Haverkamp, B., B. Bovenkerk, and M. F. Verweij. 2018. A practice-oriented review of Health concepts. Journal of Medicine and Philosophy 43: 381\u2013401. https:\/\/doi.org\/10.1093\/jmp\/jhy011","journal-title":"Journal of Medicine and Philosophy"},{"issue":"4","key":"10223_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/cer-2020-0190","volume":"10","author":"S Hendriks","year":"2021","unstructured":"Hendriks, S., and S. D. Pearson. 2021. Assessing potential cures: Are there distinctive elements of value beyond health gain? Journal of Comparative Effectiveness Research 10(4): 255\u2013265. https:\/\/doi.org\/10.2217\/cer-2020-0190","journal-title":"Journal of Comparative Effectiveness Research"},{"key":"10223_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/hae.14807","volume":"29","author":"C Hermans","year":"2023","unstructured":"Hermans, C., and G. F. Pierce. 2023. Towards achieving a haemophilia-free mind. Haemophilia 29: 951\u2013953. https:\/\/doi.org\/10.1111\/hae.14807","journal-title":"Haemophilia"},{"key":"10223_CR21","doi-asserted-by":"publisher","unstructured":"Hermans, C., E. Krumb, D. Rotellini, and G. F. Pierce. 2024. The underevaluated impacts of the therapeutic revolution of hemophilia on women and girls. Journal of Thrombosis and Haemostasis 1\u20134. https:\/\/doi.org\/10.1016\/j.jtha.2023.12.027","DOI":"10.1016\/j.jtha.2023.12.027"},{"issue":"1","key":"10223_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11013-016-9493-8","volume":"41","author":"DE Hinton","year":"2017","unstructured":"Hinton, D. E., and L. J. Kirmayer. 2017. The flexibility hypothesis of Healing. Culture Medicine and Psychiatry 41(1): 3\u201334. https:\/\/doi.org\/10.1007\/s11013-016-9493-8","journal-title":"Culture Medicine and Psychiatry"},{"issue":"4","key":"10223_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1586\/14737167.2015.1039519","volume":"15","author":"D Husereau","year":"2015","unstructured":"Husereau, D. 2015. How do we value a cure? Expert Review of Pharmacoeconomics & Outcomes Research 15(4): 551\u2013555. https:\/\/doi.org\/10.1586\/14737167.2015.1039519","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"4","key":"10223_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/MEDHUM-2023-012653","volume":"49","author":"D Kagan","year":"2023","unstructured":"Kagan, D., K. Seear, E. Lenton, A. Farrugia, K. Valentine, and S. Mulcahy. 2023. I\u2019m not hep C free\u2019: Afterlives of hepatitis C in the era of cure. Medical Humanities 49(4): 678\u2013687. https:\/\/doi.org\/10.1136\/MEDHUM-2023-012653","journal-title":"Medical Humanities"},{"key":"10223_CR26","doi-asserted-by":"crossref","unstructured":"Kimmelman, J. 2010. Gene Transfer and the Ethics of First-in-Human Research: Lost in translation. Cambridge University Press.","DOI":"10.1017\/CBO9780511642364"},{"key":"10223_CR27","doi-asserted-by":"publisher","unstructured":"Kirmayer, L. J. 2004. The cultural diversity of healing: Meaning, metaphor and mechanism. In British Medical Bulletin (Vol. 69, pp. 33\u201348). https:\/\/doi.org\/10.1093\/bmb\/ldh006","DOI":"10.1093\/bmb\/ldh006"},{"key":"10223_CR28","doi-asserted-by":"publisher","unstructured":"Krumb, E., and C. Hermans. 2021. Living with a hemophilia-free mind \u2013 the new ambition of hemophilia care? Research and Practice in Thrombosis and Haemostasis 5(5). https:\/\/doi.org\/10.1002\/RTH2.12567","DOI":"10.1002\/RTH2.12567"},{"key":"10223_CR29","doi-asserted-by":"publisher","DOI":"10.5840\/jpd20226613","author":"QR Kukla","year":"2022","unstructured":"Kukla, Q. R. 2022. What counts as a Disease, and why does it Matter? The Journal of Philosophy of Disability. https:\/\/doi.org\/10.5840\/jpd20226613","journal-title":"The Journal of Philosophy of Disability"},{"key":"10223_CR30","doi-asserted-by":"publisher","unstructured":"Linas, B. P., D. M. Barter, J. A. Leff, S. A. Assoumou, J. A. Salomon, M. C. Weinstein, A. Y. Kim, and B. R. Schackman. 2014. The hepatitis C cascade of care: Identifying priorities to improve clinical outcomes. Plos One 9(5). https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0097317","DOI":"10.1371\/JOURNAL.PONE.0097317"},{"issue":"1","key":"10223_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12954-018-0248-4\/TABLES\/1","volume":"15","author":"A Madden","year":"2018","unstructured":"Madden, A., M. Hopwood, J. Neale, and C. Treloar. 2018. Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduction Journal 15(1): 1\u20138. https:\/\/doi.org\/10.1186\/S12954-018-0248-4\/TABLES\/1","journal-title":"Harm Reduction Journal"},{"issue":"3","key":"10223_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3324\/HAEMATOL.2019.232132","volume":"105","author":"PM Mannucci","year":"2020","unstructured":"Mannucci, P. M. 2020. Hemophilia therapy: The future has begun. Haematologica 105(3): 545. https:\/\/doi.org\/10.3324\/HAEMATOL.2019.232132","journal-title":"Haematologica"},{"issue":"1","key":"10223_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/17460751.3.1.1\/FORMAT\/EPUB","volume":"3","author":"C Mason","year":"2008","unstructured":"Mason, C., and P. Dunnill. 2008. A brief definition of regenerative medicine. Regenerative Medicine 3(1): 1\u20135. https:\/\/doi.org\/10.2217\/17460751.3.1.1\/FORMAT\/EPUB","journal-title":"Regenerative Medicine"},{"issue":"4","key":"10223_CR34","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/DEAFED\/ENR017","volume":"16","author":"G McIlroy","year":"2011","unstructured":"McIlroy, G., and C. Storbeck. 2011. Development of Deaf Identity: An Ethnographic Study. The Journal of Deaf Studies and Deaf Education 16(4): 494\u2013511. https:\/\/doi.org\/10.1093\/DEAFED\/ENR017","journal-title":"The Journal of Deaf Studies and Deaf Education"},{"issue":"4","key":"10223_CR35","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1200\/JOP.2012.000806","volume":"9","author":"K Miller","year":"2013","unstructured":"Miller, K., J. H. Abraham, L. Rhodes, and R. Roberts. 2013. Use of the word cure in oncology. Journal of Oncology Practice 9(4): e136\u2013e140.","journal-title":"Journal of Oncology Practice"},{"key":"10223_CR36","doi-asserted-by":"publisher","unstructured":"Nathwani, A. C., J. McIntosh, and R. Sheridan. 2022. Liver Gene Therapy. In Human Gene Therapy (Vol. 33, Issues 17\u201318, pp. 879\u2013888). Mary Ann Liebert Inc. https:\/\/doi.org\/10.1089\/hum.2022.169","DOI":"10.1089\/hum.2022.169"},{"issue":"1","key":"10223_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11019-006-9017-3","volume":"10","author":"L Nordenfelt","year":"2007","unstructured":"Nordenfelt, L. 2007. The concepts of health and illness revisited. Medicine Health Care and Philosophy 10(1): 5\u201310. https:\/\/doi.org\/10.1007\/s11019-006-9017-3","journal-title":"Medicine Health Care and Philosophy"},{"key":"10223_CR38","doi-asserted-by":"publisher","unstructured":"Oerlemans, A. J. M., M. E. C. Van Hoek, E. Van Leeuwen, and W. J. M. Dekkers. 2014. Hype and expectations in tissue engineering. In Regenerative Medicine (Vol. 9, Issue 1, pp. 113\u2013122). https:\/\/doi.org\/10.2217\/rme.13.89","DOI":"10.2217\/rme.13.89"},{"issue":"4","key":"10223_CR39","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","volume":"9","author":"E Oru","year":"2021","unstructured":"Oru, E., A. Trickey, R. Shirali, S. Kanters, and P. Easterbrook. 2021. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: A global systematic review and meta-analysis. The Lancet Global Health 9(4): e431\u2013e445. https:\/\/doi.org\/10.1016\/S2214-109X(20)30505-2","journal-title":"The Lancet Global Health"},{"issue":"3","key":"10223_CR40","doi-asserted-by":"publisher","first-page":"e12695","DOI":"10.1002\/RTH2.12695","volume":"6","author":"MC Ozelo","year":"2022","unstructured":"Ozelo, M. C., and G. G. Yamaguti-Hayakawa. 2022. Impact of novel hemophilia therapies around the world. Research and Practice in Thrombosis and Haemostasis 6(3): e12695. https:\/\/doi.org\/10.1002\/RTH2.12695","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"7","key":"10223_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/CID\/CIR076","volume":"52","author":"BL Pearlman","year":"2011","unstructured":"Pearlman, B. L., and N. Traub. 2011. Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C virus infection: A cure and so much more. Clinical Infectious Diseases 52(7): 889\u2013900. https:\/\/doi.org\/10.1093\/CID\/CIR076","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10223_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","volume":"133","author":"GQ Perrin","year":"2019","unstructured":"Perrin, G. Q., R. W. Herzog, and D. M. Markusic. 2019. Update on clinical gene therapy for hemophilia. Blood 133(5): 407\u2013414.","journal-title":"Blood"},{"issue":"7","key":"10223_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd.2018.70","volume":"17","author":"R Peters","year":"2018","unstructured":"Peters, R., and T. Harris. 2018. Advances and innovations in haemophilia treatment. Nature Reviews Drug Discovery 17(7): 493\u2013508. https:\/\/doi.org\/10.1038\/nrd.2018.70","journal-title":"Nature Reviews Drug Discovery"},{"issue":"June","key":"10223_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14027","volume":"00","author":"SW Pipe","year":"2020","unstructured":"Pipe, S. W. 2020. Delivering on the promise of gene therapy for haemophilia. Haemophilia 00(June): 1\u20138. https:\/\/doi.org\/10.1111\/hae.14027","journal-title":"Haemophilia"},{"key":"10223_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/medethics-2019-105465","volume":"45","author":"R Powell","year":"2019","unstructured":"Powell, R., and E. Scarffe. 2019. Rethinking \u2018Disease\u2019: A fresh diagnosis and a new philosophical treatment. Journal of Medical Ethics 45: 579\u2013588. https:\/\/doi.org\/10.1136\/medethics-2019-105465","journal-title":"Journal of Medical Ethics"},{"issue":"5","key":"10223_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1049909114524477","volume":"32","author":"V Prasad","year":"2014","unstructured":"Prasad, V. 2014. Use of the Word cure in the Oncology Literature. Http:\/\/Dx Doi Org\/10 1177\/1049909114524477 32(5): 477\u2013483. https:\/\/doi.org\/10.1177\/1049909114524477","journal-title":"Http:\/\/Dx Doi Org\/10 1177\/1049909114524477"},{"issue":"1","key":"10223_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S11019-006-9020-8\/METRICS","volume":"10","author":"T Schramme","year":"2007","unstructured":"Schramme, T. 2007. A qualified defence of a naturalist theory of health. Medicine Health Care and Philosophy 10(1): 11\u201317. https:\/\/doi.org\/10.1007\/S11019-006-9020-8\/METRICS","journal-title":"Medicine Health Care and Philosophy"},{"issue":"1","key":"10223_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/1467-9566.13562","volume":"45","author":"K Seear","year":"2023","unstructured":"Seear, K., S. Mulcahy, D. Kagan, E. Lenton, S. Fraser, K. Valentine, and A. Farrugia. 2023. Complicating cure: How Australian criminal law shapes imagined post-hepatitis C futures. Sociology of Health & Illness 45(1): 179\u2013195. https:\/\/doi.org\/10.1111\/1467-9566.13562","journal-title":"Sociology of Health & Illness"},{"issue":"25","key":"10223_CR49","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMRA1712502","volume":"379","author":"CL Shapiro","year":"2018","unstructured":"Shapiro, C. L. 2018. Cancer Survivorship. New England Journal of Medicine 379(25): 2438\u20132450. https:\/\/doi.org\/10.1056\/NEJMRA1712502","journal-title":"New England Journal of Medicine"},{"key":"10223_CR50","unstructured":"Sharpless, N. E. 2018. ASCO Keynote Adress. https:\/\/www.cancer.gov\/about-nci\/leadership\/director\/presentations\/sharpless-asco-2018-transcript"},{"key":"10223_CR51","doi-asserted-by":"publisher","unstructured":"Skinner, M. W., D. P. Lillicrap, J. McMillan, M. Castro Ozelo, and G. F. Pierce. 2004. What is a cure and how do we get there? Haemophilia, 10(Suppl. 4), 115\u2013118. https:\/\/doi.org\/10.1111\/j.1365-2516.2004.00999.x","DOI":"10.1111\/j.1365-2516.2004.00999.x"},{"issue":"1","key":"10223_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/WPS.20084","volume":"13","author":"M Slade","year":"2014","unstructured":"Slade, M., M. Amering, M. Farkas, B. Hamilton, M. O\u2019Hagan, G. Panther, R. Perkins, G. Shepherd, S. Tse, and R. Whitley. 2014. Uses and abuses of recovery: Implementing recovery-oriented practices in mental health systems. World Psychiatry 13(1): 12\u201320. https:\/\/doi.org\/10.1002\/WPS.20084","journal-title":"World Psychiatry"},{"issue":"July","key":"10223_CR53","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.blre.2020.100737","volume":"46","author":"G Spadarella","year":"2020","unstructured":"Spadarella, G., A. Di Minno, N. Brunetti-Pierri, J. Mahlangu, and G. Di Minno. 2020. The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies. Blood Reviews 46(July): 100737. https:\/\/doi.org\/10.1016\/j.blre.2020.100737","journal-title":"Blood Reviews"},{"issue":"4","key":"10223_CR54","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s11948-018-0058-9","volume":"25","author":"JA Stramondo","year":"2019","unstructured":"Stramondo, J. A. 2019. The distinction between curative and assistive technology. Science and Engineering Ethics 25(4): 1125\u20131145. https:\/\/doi.org\/10.1007\/s11948-018-0058-9","journal-title":"Science and Engineering Ethics"},{"issue":"6","key":"10223_CR55","doi-asserted-by":"publisher","first-page":"e13139","DOI":"10.1111\/ECC.13139","volume":"28","author":"P Tralongo","year":"2019","unstructured":"Tralongo, P., A. Surbone, D. Serraino, and L. Dal Maso. 2019. Major patterns of cancer cure: Clinical implications. European Journal of Cancer Care 28(6): e13139. https:\/\/doi.org\/10.1111\/ECC.13139","journal-title":"European Journal of Cancer Care"},{"key":"10223_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2023.06.016","author":"LA Valentino","year":"2023","unstructured":"Valentino, L. A., R. Kaczmarek, G. F. Pierce, D. Noone, B. O\u2019Mahony, D. Page, D. Rotellini, and M. W. Skinner. 2023. Hemophilia Gene Therapy: First, do no harm. Journal of Thrombosis and Haemostasis. https:\/\/doi.org\/10.1016\/j.jtha.2023.06.016","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10223_CR57","doi-asserted-by":"publisher","first-page":"e12488","DOI":"10.1002\/RTH2.12488","volume":"5","author":"EC van Balen","year":"2021","unstructured":"van Balen, E. C., B. O\u2019Mahony, M. H. Cnossen, G. Dolan, V. S. Blanchette, K. Fischer, D. Gue, J. O\u2019Hara, A. Iorio, S. Jackson, B. A. Konkle, D. J. Nugent, D. Coffin, M. W. Skinner, C. Smit, A. Srivastava, F. van Eenennaam, J. G. van der Bom, and S. C. Gouw. 2021. Patient-relevant health outcomes for hemophilia care: Development of an international standard outcomes set. Research and Practice in Thrombosis and Haemostasis 5(4): e12488. https:\/\/doi.org\/10.1002\/RTH2.12488","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"26","key":"10223_CR58","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1056\/nejme1713888","volume":"377","author":"HM van den Berg","year":"2017","unstructured":"van den Berg, H. M. 2017. A cure for Hemophilia within Reach. New England Journal of Medicine 377(26): 2592\u20132593. https:\/\/doi.org\/10.1056\/nejme1713888","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10223_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11019-021-10058-9","volume":"25","author":"R van der Linden","year":"2022","unstructured":"van der Linden, R., and M. Schermer. 2022. Health and disease as practical concepts: Exploring function in context-specific definitions. Medicine Health Care and Philosophy 25(1): 131\u2013140. https:\/\/doi.org\/10.1007\/s11019-021-10058-9","journal-title":"Medicine Health Care and Philosophy"},{"issue":"1","key":"10223_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/WPS.20609","volume":"18","author":"J van Os","year":"2019","unstructured":"van Os, J., S. Guloksuz, T. W. Vijn, A. Hafkenscheid, and P. Delespaul. 2019. The evidence-based group-level symptom-reduction model as the organizing principle for mental health care: Time for change? World Psychiatry 18(1): 88\u201396. https:\/\/doi.org\/10.1002\/WPS.20609","journal-title":"World Psychiatry"},{"key":"10223_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/HAE.13449","volume":"24","author":"LFD van Vulpen","year":"2018","unstructured":"van Vulpen, L. F. D., K. Holstein, and C. Martinoli. 2018. Joint disease in haemophilia: Pathophysiology, pain and imaging. Haemophilia 24: 44\u201349. https:\/\/doi.org\/10.1111\/HAE.13449","journal-title":"Haemophilia"},{"issue":"3","key":"10223_CR62","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1037\/0003-066X.47.3.373","volume":"47","author":"JC Wakefield","year":"1992","unstructured":"Wakefield, J. C. 1992. The concept of mental disorder: On the boundary between biological facts and social values. American Psychologist 47(3): 373\u2013388. https:\/\/doi.org\/10.1037\/0003-066X.47.3.373","journal-title":"American Psychologist"},{"issue":"3","key":"10223_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/WPS.20238","volume":"14","author":"BE Wampold","year":"2015","unstructured":"Wampold, B. E. 2015. How important are the common factors in psychotherapy? An update. World Psychiatry 14(3): 270\u2013277. https:\/\/doi.org\/10.1002\/WPS.20238","journal-title":"World Psychiatry"},{"key":"10223_CR64","unstructured":"Zhang, S. 2018. Why I Don\u2019t Want to Cure My Hemophilia With Gene Therapy. The Atlantic. https:\/\/www.theatlantic.com\/science\/archive\/2018\/08\/hemophilia-gene-therapy-cure-identity\/540987\/"},{"key":"10223_CR65","unstructured":"Zorginstituut Nederland. 2022. Pakketadvies sluisgeneesmiddel atidarsagene autotemcel (Libmeldy). www.zorginstituutnederland.nl"}],"container-title":["Medicine, Health Care and Philosophy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-024-10223-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11019-024-10223-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-024-10223-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T12:21:57Z","timestamp":1730118117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11019-024-10223-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10223"],"URL":"https:\/\/doi.org\/10.1007\/s11019-024-10223-w","relation":{},"ISSN":["1386-7423","1572-8633"],"issn-type":[{"value":"1386-7423","type":"print"},{"value":"1572-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"5 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Meijer reports speaker fees from Alexion, Bayer and CSL Behring, participation in trial steering committees for Bayer and Astra Zeneca, consulting fees from Uniqure and Therini, participation in data monitoring and endpoint adjudication committee for Octapharma. All other authors have no competing interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}